Atlas Trials

A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection

Clinical trial NCT04392232 · COMPLETED

Trial details

NCT number
NCT04392232
Sponsor
TriHealth Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
CoronavirusCOVID-19Convalescent Plasma
Start date
2020-05-05
Primary completion
2021-09-21
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.